Allogeneic adipose-derived mesenchymal stem cells therapy (The Methodist Hospital Research Institute)

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameAllogeneic adipose-derived mesenchymal stem cells therapy (The Methodist Hospital Research Institute)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derivedCell and gene therapy > Cell therapy > Donor > Allogeneic

Mechanisms of ActionStem cell replacements

TargetsUpdating

Therapy Area/IndicationsErectile DysfunctionProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesThe Methodist Hospital Research Institute

China Registration ClassN/A

Develop Information

Active CompaniesThe Methodist Hospital Research Institute

Inactive CompaniesN/A

Active IndicationsErectile DysfunctionProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A